New clinical trial with genomics focus may offer fresh hope for blood cancer patients
- Clinical trials
- Media releases
- Research
Two new international clinical trials are expected to improve access to new therapies for Australians with MDS as part of the Leukaemia Foundation’s Trials Enabling Program (TEP).
A lot of ‘world firsts’ are involved in an Australian clinical trial that is taking a precision medicine approach to treating CMML, a neglected and serious rare blood cancer that is poorly understood.
Two clinical trials will open later this year for newly diagnosed patients with AL amyloidosis with moderate to severe cardiac disease.
Information on the latest clinical trial.
Four clinical trials run by the Australasian Leukaemia & Lymphoma Group* (ALLG) are currently open to a range of people with acute myeloid leukaemia (AML) across Australia.
Deborah Henderson kissed her children goodbye and moved to London in the hope of getting on a clinical trial.
The treatment for newly diagnosed MDS will be available “very soon” to Australians in a clinical trial.
Matthew Fogarty has spent almost five years regularly travelling to the other side of the world to collect the handful of pills that keep his blood cancer at bay.